Search results
Results from the WOW.Com Content Network
Regeneron (REGN) announces encouraging initial data from its seamless phase I/II/III study, evaluating antibody cocktail candidate, REGN-COV2, in non-hospitalized patients with COVID-19.
The University of Montreal and Mila created the "COVID-19 Image Data Collection" in March which is a public data repository of chest imaging. [ 25 ] [ 26 ] [ 27 ] The Medical Imaging Databank in Valencian Region released a large dataset of chest imaging from Spain.
The development of COVID-19 tests was a major public health priority during the early months of the COVID-19 pandemic. In January 2020, scientists from China published the first genetic sequences of SARS-CoV-2 via virological.org , [ 3 ] a "hub for prepublication data designed to assist with public health activities and research". [ 4 ]
'The corona pandemic in Israel') is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in Israel was confirmed on 21 February 2020, when a female citizen tested positive for COVID-19 at the Sheba Medical Center after return from quarantine on the ...
For premium support please call: 800-290-4726 more ways to reach us
An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
A drug company says that partial results from a study testing an antibody drug give hints that it may help keep mild to moderately ill COVID-19 patients from needing to be hospitalized, a goal no ...